Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Salicylanilide compounds show promise for treating COVID-19

Aug. 23, 2021

KIN-001 for COVID-19 shows preclinical antiviral, anti-inflammatory and antifibrotic activity

Aug. 23, 2021

A virus-specific nanobody lowers latent viral loads in HCMV-infected cells

Aug. 23, 2021

Rare gene variants increase zoonotic H7N9 susceptibility

Aug. 20, 2021

Persica completes first stage of clinical trial on PP-353 for low back pain

Aug. 20, 2021

"Not just the flu" holds for SARS-CoV-2 long-term effects, too

Aug. 19, 2021

Roche discloses new antibacterials

Aug. 19, 2021

Eisai describes new compounds for malaria

Aug. 19, 2021

Assembly Biosciences to advance anti-HBV agent ABI-4334 to the clinic

Aug. 19, 2021

ExeVir's COVID-19 treatment and prophylactic XVR-011 enters clinical study

Aug. 18, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...